Table 1.
Baseline characteristics of 20 133 patients with coronavirus disease 2019 stratified by sex. Data are numbers (percentages) unless stated otherwise
| Characteristics | Male | Female | All |
|---|---|---|---|
| Total No (%) | 12 068 (59.9) | 8065 (40.1) | 20 133 |
| Age at admission (n=20 133) | |||
| Median (interquartile range) | 72.0 (58.0-81.0) | 74.0 (58.0-84.0) | 72.9 (58.0-82.0) |
| Age (n=20 133) | |||
| <18 | 180 (1.5) | 130 (1.6) | 310 (1.5) |
| 18-39 | 534 (4.4) | 533 (6.6) | 1067 (5.3) |
| 40-50 | 888 (7.4) | 530 (6.6) | 1418 (7.0) |
| 50-59 | 1728 (14.3) | 980 (12.2) | 2708 (13.5) |
| 60-69 | 2115 (17.5) | 1181 (14.6) | 3296 (16.4) |
| 70-79 | 2972 (24.6) | 1720 (21.3) | 4692 (23.3) |
| ≥80 | 3651 (30.3) | 2991 (37.1) | 6642 (33.0) |
| Any comorbidity (n=18 525) | |||
| No | 2591 (23.4) | 1570 (21.1) | 4161 (22.5) |
| Yes | 8492 (76.6) | 5872 (78.9) | 14 364 (77.5) |
| Chronic cardiac disease (n=17 702) | |||
| No | 7086 (66.8) | 5147 (72.6) | 12 233 (69.1) |
| Yes | 3527 (33.2) | 1942 (27.4) | 5469 (30.9) |
| Chronic pulmonary disease, not asthma (n=17 634) | |||
| No | 8616 (81.7) | 5890 (83.1) | 14 506 (82.3) |
| Yes | 1931 (18.3) | 1197 (16.9) | 3128 (17.7) |
| Asthma (n=17 535) | |||
| No | 9274 (88.6) | 5721 (80.9) | 14 995 (85.5) |
| Yes | 1192 (11.4) | 1348 (19.1) | 2540 (14.5) |
| Smoker (n=14 184) | |||
| Never smoked | 5030 (58.8) | 3938 (69.9) | 8968 (63.2) |
| Former smoker | 2972 (34.8) | 1392 (24.7) | 4364 (30.8) |
| Yes | 549 (6.4) | 303 (5.4) | 852 (6.0) |
| Chronic kidney disease (n=17 506) | |||
| No | 8792 (84.0) | 5884 (83.5) | 14 676 (83.8) |
| Yes | 1671 (16.0) | 1159 (16.5) | 2830 (16.2) |
| Diabetes without complications (n=17 599) | |||
| No | 8254 (78.3) | 5695 (80.7) | 13 949 (79.3) |
| Yes | 2290 (21.7) | 1360 (19.3) | 3650 (20.7) |
| Diabetes with complications (n=17 516) | |||
| No | 9628 (91.8) | 6589 (93.8) | 16 217 (92.6) |
| Yes | 860 (8.2) | 439 (6.2) | 1299 (7.4) |
| Obesity (n=16 081) | |||
| No | 8725 (90.6) | 5671 (87.8) | 14 396 (89.5) |
| Yes | 900 (9.4) | 785 (12.2) | 1685 (10.5) |
| Chronic neurological disorder (n=17 382) | |||
| No | 9222 (88.6) | 6189 (88.7) | 15 411 (88.7) |
| Yes | 1181 (11.4) | 790 (11.3) | 1971 (11.3) |
| Dementia (n=17 459) | |||
| No | 9211 (88.2) | 5888 (83.9) | 15 099 (86.5) |
| Yes | 1232 (11.8) | 1128 (16.1) | 2360 (13.5) |
| Malignancy (n=17 354) | |||
| No | 9251 (89.2) | 6360 (91.0) | 15 611 (90.0) |
| Yes | 1117 (10.8) | 626 (9.0) | 1743 (10.0) |
| Moderate or severe liver disease (n=17 360) | |||
| No | 10 181 (98.0) | 6869 (98.5) | 17 050 (98.2) |
| Yes | 204 (2.0) | 106 (1.5) | 310 (1.8) |
| Mild liver disease (n=17 331) | |||
| No | 10 195 (98.3) | 6855 (98.5) | 17 050 (98.4) |
| Yes | 174 (1.7) | 107 (1.5) | 281 (1.6) |
| Chronic haematological disease (n=17 328) | |||
| No | 9951 (96.0) | 6684 (96.0) | 16 635 (96.0) |
| Yes | 415 (4.0) | 278 (4.0) | 693 (4.0) |
| Rheumatological disorder (n=17 289) | |||
| No | 9562 (92.4) | 6031 (86.9) | 15 593 (90.2) |
| Yes | 787 (7.6) | 909 (13.1) | 1696 (9.8) |
| Malnutrition (n=16 695) | |||
| No | 9768 (97.8) | 6531 (97.4) | 16 299 (97.6) |
| Yes | 222 (2.2) | 174 (2.6) | 396 (2.4) |
| Previous immunosuppressant drug treatment (n=18 009) | |||
| Yes | 876 (8.1) | 791 (11.0) | 1667 (9.3) |
| No | 9339 (86.6) | 6032 (83.5) | 15 371 (85.4) |
| Not applicable | 573 (5.3) | 398 (5.5) | 971 (5.4) |
| Previous anti-infective treatment (n=18 017) | |||
| No | 1940 (18.0) | 1311 (18.2) | 3251 (18.0) |
| Yes | 8285 (76.8) | 5520 (76.4) | 13 805 (76.6) |
| Not applicable | 569 (5.3) | 392 (5.4) | 961 (5.3) |
| AIDS/HIV (n=17 251) | |||
| No | 10 259 (99.5) | 6909 (99.6) | 17 168 (99.5) |
| Yes | 55 (0.5) | 28 (0.4) | 83 (0.5) |